GASTROENTEROLOGY (IBD/IBS/CHRON'S/ULCERATIVE COLITIS)
IBD Biomarker Panel
Comprehensive Inflammatory Marker Detection
Multi-marker detection for inflammatory bowel disease diagnosis, monitoring, and progression assessment in clinical practice
The IBD Biomarker Panel is an advanced multiplex ELISA system designed for comprehensive assessment of inflammatory bowel disease. By simultaneously detecting three key biomarkers (Calprotectin, Lactoferrin, and S100A12), this panel provides clinicians with critical diagnostic and prognostic information for IBD, IBS, Crohn's disease, and ulcerative colitis.
Product Specifications
Sample Types
Serum, Plasma, Stool
Biomarkers Detected
Calprotectin, Lactoferrin, S100A12
Incubation Time
60 minutes at 37°C
Calibrators
5 levels + 2 control samples
ControlSamples
1 level included
Sensitivity
>92%
Specificity
>96%
Shelf Life
18 months at 2-8°C
Format
96-well multiplex ELISA plate
Key Features & Information
Triple biomarker detection: Comprehensive assessment in single test run
Advanced multiplex ELISA technology: Simultaneous testing of three markers
Disease monitoring capability: Track inflammation progression over time
Multiple sample types: Serum, plasma, and stool compatibility
Validated for IBD, IBS, Crohn's disease, and ulcerative colitis applications
High accuracy: Sensitivity >92%, Specificity >96% for disease differentiation
Request Information
Interested in IBD Biomarker Panel? Fill out the form below and our team will contact you with detailed information and pricing.